CVS Health Corporation $CVS Stock Holdings Raised by International Assets Investment Management LLC

International Assets Investment Management LLC lifted its position in shares of CVS Health Corporation (NYSE:CVS) by 1,198.5% in the 3rd quarter, Holdings Channel.com reports. The fund owned 180,000 shares of the pharmacy operator’s stock after buying an additional 166,138 shares during the quarter. International Assets Investment Management LLC’s holdings in CVS Health were worth $15,424,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Handelsbanken Fonder AB increased its holdings in CVS Health by 83.6% in the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock worth $112,729,000 after buying an additional 496,124 shares in the last quarter. BNP Paribas lifted its stake in CVS Health by 105.2% during the 2nd quarter. BNP Paribas now owns 49,971 shares of the pharmacy operator’s stock valued at $5,154,000 after acquiring an additional 25,617 shares during the period. Nykredit A S bought a new position in CVS Health during the 2nd quarter valued at about $209,813,000. Oppenheimer Asset Management Inc. purchased a new stake in shares of CVS Health during the 2nd quarter valued at about $49,622,000. Finally, Bank of America Corp DE boosted its holdings in shares of CVS Health by 148.0% during the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after acquiring an additional 13,836,701 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Trading Down 0.1%

CVS Health stock opened at $90.20 on Friday. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68. The company has a market cap of $115.36 billion, a P/E ratio of 23.86, a P/E/G ratio of 0.84 and a beta of 0.60. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The business has a 50-day simple moving average of $91.22 and a two-hundred day simple moving average of $88.76.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts predict that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be given a $0.6650 dividend. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 2.9%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CVS. Robert W. Baird set a $107.00 price target on shares of CVS Health in a research note on Thursday, August 6th. Weiss Ratings downgraded shares of CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 9th. Truist Financial raised their target price on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Leerink Partners cut their target price on shares of CVS Health from $119.00 to $112.00 and set an “outperform” rating for the company in a research report on Monday, October 12th. Finally, UBS Group reiterated a “buy” rating on shares of CVS Health in a research note on Tuesday, September 22nd. Nineteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $109.64.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: One valuation analysis estimates that CVS could be approximately 27% undervalued, citing its low valuation and expectations that upcoming earnings will clarify performance across its pharmacy, insurance and healthcare-services businesses. CVS Health Could Be 27% Undervalued
• Positive Sentiment: CVS is promoting free Project Health screenings that require no appointment or insurance. Although primarily a community-health initiative, the program may support customer engagement and the company’s broader healthcare strategy. CVS Project Health Screenings
• Neutral Sentiment: Wall Street is reportedly expecting about $1.62 in third-quarter earnings per share, with analysts examining metrics beyond revenue and EPS, including segment trends and operating performance. The results could provide an important catalyst after CVS’s previous quarterly earnings beat. CVS Q3 Earnings Estimates
• Neutral Sentiment: CVS is highlighting medication-safety education and substance-misuse prevention resources. The initiative strengthens its public-health positioning but is unlikely to materially affect near-term earnings. CVS Medication Safety Initiative
• Negative Sentiment: CVS faces a reported risk of roughly $2 billion related to Medicare Advantage star ratings. Lower ratings could reduce bonus payments and pressure profitability in its insurance business. CVS Medicare Ratings Risk
• Negative Sentiment: Six hospital systems, including the University of Kentucky, reportedly accuse CVS of fraud or contract breaches, with the Kentucky lawsuit seeking $41 million. Even if the claims are unresolved, additional litigation raises potential legal costs and reputational risk. Hospital Systems Sue CVS

CVS Health Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.